AJN American Journal of Nephrology - Karger Publishers

Vol. 51, 2020

Basel • Freiburg • Hartford • Oxford • Bangkok • Dubai • Kuala Lumpur • Melbourne • Mexico City • Moscow • New Delhi • Paris • Shanghai • Tokyo

Founded 1981 and edited until 2002 by S.G. Massry

Editor-in-Chief

George L. Bakris – University of Chicago Medicine, Chicago, IL, USA

Associate Editors

Rajiv Agarwal – Indiana University, Indianapolis, IN, USARichard J. Glassock – University of California Los Angeles, Laguna Niguel, CA, USABiff F. Palmer – University of Texas Southwestern Medical Center, Dallas, TX, USAStuart M. Sprague – University of Chicago, Chicago, IL, USAMatthew R. Weir – University of Maryland School of Medicine, Baltimore, MD, USA

Administrative Assistant

Barbara Brisky – University of Chicago Medicine, Chicago, IL, USA

Editorial Board

Phyllis August – Weill Cornell Medicine, New York, NY, USAAtul Bali – University of Virginia, Farmville, VA, USAVinod K. Bansal – Loyola University, Maywood, IL, USAEnrico Benedetti – University of Illinois at Chicago, Chicago, IL, USAPeter Blake – London Health Science Center, London, ON, CanadaAndrew Bomback – Columbia University College of Physicians and Surgeons,

New York, NY, USAMichel Burnier – University of Lausanne, Lausanne, SwitzerlandAlejandro R. Chade – University of Mississippi Medical Center, Jackson, MS, USAChristopher Chan – University Health Network, University of Toronto, Toronto, ON,

CanadaJohn Cockcroft – Wales Heart Research Institute, Cardiff, UKMark E. Cooper – Monash University, Melbourne, VIC, AustraliaJohn T. Daugirdas – University of Illinois at Chicago, Chicago, IL, USASteven Fishbane – Donald and Barbara Zucker School of Medicine at Hofstra/Northwell,

Great Neck, NY, USAAgnes B. Fogo – Vanderbilt University Medical Center, Nashville, TN, USA

AJNAmerican Journal of Nephrology

(Continued on next page)

© 2020 S. Karger AG, [email protected]

Barry I. Freedman – Wake Forest School of Medicine, Winston-Salem, NC, USAGuillermo Garcia-Garcia – University of Guadalajara Health Sciences Center,

Guadalajara, MexicoIgnacio Garcia-Gomez – Northwestern University, Chicago, IL, USAMary Hammes – University of Chicago Medicine, Chicago, IL, USAMarion A. Hofmann Bowman – University of Michigan, Ann Arbor, MI, USAJoachim H. Ix – University of California San Diego, San Diego, CA, USARichard Johnson – University of Colorado Denver, Aurora, CO, USAMichelle A. Josephson – University of Chicago, Chicago, IL, USAKamyar Kalantar-Zadeh – University of California Irvine, Orange, CA, USAJeffrey B. Kopp – NIDDK, NIH, Bethesda, MD, USAJay L. Koyner – University of Chicago, Chicago, IL, USAElaine Ku – University of California San Francisco, San Francisco, CA, USADavid Leehey – Loyola University, Maywood, IL, USAMichael Lipkowitz – Georgetown University Medical Center, Washington, DC, USASharon Moe – Indiana University, Indianapolis, IN, USAMasaomi Nangaku – University of Tokyo, Tokyo, JapanSankar D. Navaneethan – Baylor College of Medicine, Houston, TX, USAShivanand Nayak – Virinchi Hospital, Hyderabad, IndiaLavinia A. Negrea – University Hospitals Cleveland Medical Center, Cleveland, OH, USASusanne B. Nicholas – University of California Los Angeles, Los Angeles, CA, USAMark D. Okusa – University of Virginia, Charlottesville, VA, USAVasilios Papademetriou – Georgetown University, Washington, DC, USAAldo J. Peixoto – Yale School of Medicine, New Haven, CT, USAVlado Perkovic – University of New South Wales, Sydney, NSW, AustraliaMahboob Rahman – Case Western Reserve University, Cleveland, OH, USAGiuseppe Remuzzi – Mario Negri Institute for Pharmacological Research, Bergamo, ItalyLaszlo Rosivall – Semmelweis University, Budapest, HungaryEdward A. Ross – University of Central Florida, Orlando, FL, USAPatrick Rossignol – University of Lorraine, INSERM, CHRU NANCY and FCRIN INI-CRCT,

Nancy, FranceMichael R. Rudnick – University of Pennsylvania, Philadelphia, PA, USAGamal Saadi – Cairo University, Cairo, EgyptRamin Sam – University of California San Francisco, San Francisco, CA, USAPantelis Sarafidis – Aristotle University of Thessaloniki, Thessaloniki, GreeceJohn Sedor – Case Western Reserve University, Cleveland, OH, USAKumar Sharma – University of Texas Health San Antonio, San Antonio, TX, USATitte R. Srinivas – Intermountain Healthcare, Murray, UT, USAHiromichi Suzuki – Musashinotokusyukai Hospital, Tokyo, JapanSydney C.W. Tang – University of Hong Kong, Hong Kong SAR, ChinaRavi Thadhani – Harvard Medical School, Boston, MA, USAVisith Thongboonkerd – Siriraj Hospital, Mahidol University, Bangkok, ThailandChris Tikellis – Baker Heart Institute, Melbourne, VIC, Australia

(Continued)

(Continued on next page)

George Tsirpanlis – General Hospital of Athens “G. Gennimatas”, Athens, GreeceAngela Yee-Moon Wang – Queen Mary Hospital, The University of Hong Kong SAR,

Hong Kong SAR, ChinaDonald E. Wesson – Texas A&M College of Medicine, Dallas, TX, USAAdam Whaley-Connell – University of Missouri, Columbia, MO, USAWolfgang C. Winkelmayer – Baylor College of Medicine, Houston, TX, USAJerry Yee – Henry Ford Health System, Detroit, MI, USAYing-Yong Zhao – Northwest University, Xi’an, ChinaCarmine Zoccali – CNR IFC, Clinical Epidemiology of Renal Diseases and Hypertension,

Reggio Calabria, Italy

Visual Abstract Editors

Divya Bajpai, Mumbai, IndiaAldo R. Jimenez Vega – ISSSTE, Los Mochis, MexicoEdgar V. Lerma – University of Illinois at Chicago College of Medicine/Advocate Christ

Medical Center, Oak Lawn, IL, USAAakash Shingada – Lancelot Kidney Centre, Mumbai, IndiaOmar Taco Sánchez – Hospital Universitari Germans Trias i Pujol, Barcelona, SpainJoel M. Topf – St Clair Specialty Physicians, Roseville, MI, USA

(Continued)

© 2020 S. Karger AG, [email protected]

[email protected] www.karger.com

S. KargerMedical and Scientific PublishersBasel • Freiburg • Hartford • Oxford • Bangkok • Dubai • Kuala Lumpur • Melbourne • Mexico City • Moscow • New Delhi • Paris • Shanghai • Tokyo

DisclaimerThe statements, opinions and data contained in this publica-tion are solely those of the individual authors and contributors and not of the publisher and the editor(s). The appearance of advertisements in the journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Drug DosageThe authors and the publisher have exerted every effort to en-sure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of informa-tion relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precau-tions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.

All rights reserved.No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center (see “General Information”).

© Copyright 2020/2021 by S. Karger AG,CH–4009 Basel (Switzerland)Printed on acid-free and non-aging paper (ISO 9706)

No. 1

Laboratory Investigation: Research Article

1 A Sphingosine-1-Phosphate Modulator Ameliorates Polycystic Kidney Disease in Han:SPRD RatsLi, X.; Wu, M. (Shanghai); Chen, L. (Shanghai/Nanchang); Lu, J.; Li, G.; Fu, L.; Qi, N.; Lin, Y. (Shanghai); Sun, Z. (Nanchang); Wang, X.; Zhang, H.; Liu, J.; Jiang, H.; Li, L.; Mei, C.-L.; Luo, C. (Shanghai)

Patient-Oriented, Translational Research: Research Articles

11 Increasing Nephrologist Awareness of Symptom Burden in Older Hospitalized End-Stage Renal Disease PatientsJawed, A. (Detroit, MI); Moe, S.M.; Moorthi, R.N.; Torke, A.M.; Eadon, M.T. (Indianapolis, IN)

17 Validation of a Risk Equation Predicting Hemodialysis Arteriovenous Fistula Primary Failure in ElderlyQian, J.Z. (Bethesda, MD/Baltimore, MD); McAdams-DeMarco, M.A.; Ng, D.; Lau, B. (Baltimore, MD)

24 Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease PatientsKittiskulnam, P.; Srijaruneruang, S.; Chulakadabba, A.; Thokanit, N.S.; Praditpornsilpa, K.; Tungsanga, K.; Eiam-Ong, S. (Bangkok)

35 Matters of Life and Death: Why Do Older Patients Choose Conservative Management?Saeed, F.; Adams, H.; Epstein, R.M. (Rochester, NY)

43 Utility of Genomic Testing after Renal BiopsyMurray, S.L.; Dorman, A.; Benson, K.A. (Dublin); Connaughton, D.M. (Dublin/Boston, MA); Stapleton, C.P.; Fennelly, N.K.; Kennedy, C.; McDonnell, C.A. (Dublin); Kidd, K. (Winston-Salem, NC); Cormican, S.M.; Ryan, L.A.; Lavin, P.; Little, M.A. (Dublin); Bleyer, A.J. (Winston-Salem, NC); Doyle, B.; Cavalleri, G.L. (Dublin); Hildebrandt, F. (Boston, MA); Conlon, P.J. (Dublin)

54 Analysis of Factors Influencing the Prognostic Significance of Hyponatremia in Peritoneal Dialysis PatientsBravo González-Blas, L.; García-Gago, L.; Astudillo-Jarrín, D.; Rodríguez-Magariños, C.; López-Iglesias, A.; García Falcón, T.; Rodríguez-Carmona, A.; Pérez Fontán, M. (A Coruña)

Novel Research Findings

65 Parathyroidectomy Influences Coronary Artery Calcium Score in Asymptomatic Hemodialysis Patients with Secondary HyperparathyroidismMa, Q.; Su, D.; Liu, F.; Xing, H.; Han, X.; Ma, D. (Beijing)

74 Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes MellitusCherney, D.Z.I. (Toronto, ON); Repetto, E. (Gaithersburg, MD); Wheeler, D.C. (London/Sydney, NSW); Arnold, S.V. (Kansas City, MO); MacLachlan, S. (London); Hunt, P.R.; Chen, H. (Gaithersburg, MD); Vora, J. (Liverpool); Kosiborod, M. (Kansas City, MO/Sydney, NSW)

No. 2

Editorials

83 Circulating Endocannabinoid Levels as Potential Biomarkers for Mortality in Hemodialysis PatientsBeberashvili, I. (Zerifin)

96 Membranous Nephropathy Due to Anti-GBM Antibodies of Mice and MenGlassock, R.J. (Los Angeles, CA)

In-Depth Topic Review

108 Management of Presumed Acute Kidney Injury during Hypertensive Therapy: Stay Calm and Carry on?Chen, T.K.; Parikh, C.R. (Baltimore, MD)

Transplantation: Research Article

116 APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-EffectivenessGudsoorkar, P.; Anand, M.; Abu Jawdeh, B.G. (Cincinnati, OH)


119 Renal Anti-Fibrotic Effect of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent HypertensionCastoldi, G. (Monza); Carletti, R. (Rome); Ippolito, S.; Colzani, M.; Barzaghi, F.; Stella, A. (Monza); Zerbini, G. (Milan); Perseghin, G. (Monza); di Gioia, C.R.T. (Rome)


86 Circulating Endocannabinoids and Mortality in Hemodialysis PatientsMoradi, H. (Irvine, CA/Long Beach, CA); Park, C. (Irvine, CA); Streja, E. (Irvine, CA/Long Beach, CA); Argueta, D.A.; DiPatrizio, N.V. (Riverside, CA); You, A.S.; Rhee, C.M.; Vaziri, N.D. (Irvine, CA); Kalantar-Zadeh, K. (Irvine, CA/Long Beach, CA); Piomelli, D. (Irvine, CA)

130 Novel Model Predicts Diabetic Nephropathy in Type 2 DiabetesJiang, S.; Fang, J.; Yu, T.; Liu, L.; Zou, G.; Gao, H.; Zhuo, L.; Li, W. (Beijing)

139 Effect of Ultrafiltration on Sleep Apnea and Cardiac Function in End-Stage Renal DiseaseInami, T.; Lyons, O.D.; Perger, E.; Yadollahi, A.; Floras, J.S.; Chan, C.T.; Bradley, T.D. (Toronto, ON)

160 Calcium-Alkali Syndrome Associated with Hypoparathyroidism Following Total ThyroidectomyKuroya, S.; Yazawa, M.; Shibagaki, Y.; Tominaga, N. (Kanagawa)

Contents Vol. 51, 2020

[email protected] www.karger.com

© 2020/2021 S. Karger AG, Basel

Access to full text and tables of contents, including tentative ones for forthcoming issues: www.karger.com/ajn_issues

VI ContentsAm J Nephrol Vol. 51, 2020


99 Epitope Mapping of Human α3(IV)NC1-Induced Membranous Nephropathy in MiceWang, J.; Wang, M.; Cui, Z.; Zhao, M. (Beijing)

147 Research Themes and Trends in Ten Top-Ranked Nephrology Journals: A Text Mining AnalysisZengul, F.D.; Lee, T. (Birmingham, AL); Delen, D. (Stillwater, OK); Almehmi, A.; Ivankova, N.V.; Mehta, T. (Birmingham, AL); Topuz, K. (Tulsa, OK)

168 Erratum

No. 3

Editorial

169 Acute Kidney Injury: To Be or Not to Be: That Is the Question: It’s the Company It KeepsPiña, I.L. (Detroit, MI)


182 Sodium Fate after Sodium Bicarbonate Infusion: Influence of Altered Acid-Base StatusAdrogué, H.J.; Awan, A.A. (Houston, TX); Madias, N.E. (Boston, MA)


192 Comparing Patient Survival of Home Hemodialysis and Peritoneal Dialysis PatientsChoi, S.J. (Orange, CA/Bucheon); Obi, Y. (Orange, CA); Ko, G.J. (Orange, CA/Seoul); You, A.S.; Eriguchi, R. (Orange, CA); Wang, M. (Orange, CA/Shanghai); Rhee, C.M. (Orange, CA); Kalantar-Zadeh, K. (Orange, CA/Los Angeles, CA/Long Beach, CA)

201 Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the IMpact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease TrialLioufas, N.M. (Parkville, VIC/Melbourne, VIC); Pedagogos, E. (Parkville, VIC/Melbourne, VIC); Hawley, C.M. (Brisbane, QLD/Woolloongabba, QLD); Pascoe, E.M. (Brisbane, QLD); Elder, G.J. (Westmead, NSW/Darlinghurst, NSW); Badve, S.V. (Sydney, NSW); Valks, A. (Brisbane, QLD); Toussaint, N.D. (Parkville, VIC)

216 Pregnancy-Related Acute Kidney Injury in the United States: Clinical Outcomes and Health Care UtilizationShah, S.; Meganathan, K.; Christianson, A.L.; Harrison, K.; Leonard, A.C.; Thakar, C.V. (Cincinnati, OH)

227 Factors Associated with Elective Withdrawal of Maintenance Hemodialysis: A Case-Control AnalysisWetmore, J.B.; Yan, H.; Gilbertson, D.T.; Liu, J. (Minneapolis, MN)

237 Glucose Exposure in Peritoneal Dialysis Is a Significant Factor Predicting PeritonitisUiterwijk, H.; Franssen, C.F.M.; Kuipers, J.; Westerhuis, R.; Nauta, F.L. (Groningen)

Perspective

244 Nephrology Training: Time to Revisit Integrative PhysiologyBansal, S.; Kanakia, R.; Sharma, K.; Tsai, S.; Prasad, A. (San Antonio, TX)


172 Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation HospitalizationWalther, C.P.; Winkelmayer, W.C.; Deswal, A.; Niu, J.; Navaneethan, S.D. (Houston, TX)

249 Improved Sleep Quality Improves Blood Pressure Control among Patients with Chronic Kidney Disease: A Pilot StudyAli, W.; Gao, G.; Bakris, G.L. (Chicago, IL)

No. 4

World Kidney Day 2020: Editorial

255 Kidney Health for Everyone Everywhere – From Prevention to Detection and Equitable Access to CareLi, P.K.-T. (Hong Kong); Garcia-Garcia, G. (Guadalajara); Lui, S.-F. (Hong Kong); Andreoli, S. (Indianapolis, IN); Fung, W.W.-S. (Hong Kong); Hradsky, A. (Brussels); Kumaraswami, L. (Chennai); Liakopoulos, V. (Thessaloniki); Rakhimova, Z. (Brussels); Saadi, G. (Giza); Strani, L. (Brussels); Ulasi, I. (Ituku-Ozalla); Kalantar-Zadeh, K. (Orange, CA); for the World Kidney Day Steering Committee

Editorial

263 Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers after Acute Kidney Injury: Friend, Foe, or Acquaintance?Coca, S.G. (New York, NY)


276 Renal and Cardiovascular Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease: Perspectives on the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial ResultsWeir, M.R. (Baltimore, MD); McCullough, P.A. (Dallas, TX); Buse, J.B. (Chapel Hill, NC); Anderson, J. (Nashville, TN)


294 Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney DiseaseGil-Ortega, M.; Vega-Martín, E.; Martín-Ramos, M.; González-Blázquez, R.; Pulido-Olmo, H.; Ruiz-Hurtado, G. (Madrid); Schulz, A. (Berlin); Ruilope, L.M. (Madrid); Kolkhof, P. (Wuppertal); Somoza, B. (Madrid); Kreutz, R. (Berlin); Fernández-Alfonso, M.S. (Madrid)


304 Membranous Nephropathy in PregnancyLiu, Z.; Cui, Z.; He, Y.; Zhang, Y.; Wang, F.; Wang, X.; Meng, L.; Cheng, X.; Liu, G.; Zhao, M. (Beijing)

318 Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care UnitAllegretti, A.S.; Endres, P. (Boston, MA); Parris, T. (Boston, MA/ Mobile, AL); Zhao, S.; May, M.; Sylvia-Reardon, M.; Bezreh, N.; Culbert-Costley, R.; Ananian, L.; Roberts, R.J.; Lopez, N. (Boston, MA); Charytan, D.M. (New York, NY); Tolkoff-Rubin, N. (Boston, MA)

327 Treatment Outcomes of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Patients Over Age 75 Years: A Meta-AnalysisMorris, A.D.; Elsayed, M.E.; Ponnusamy, A.; Rowbottom, A.; Martin, F. (Preston); Geetha, D. (Baltimore, MD); Dhaygude, A.P. (Preston)

VIIContents Am J Nephrol Vol. 51, 2020

Perspective

289 Mitigation of the Adverse Consequences of Nutrient Excess on the Kidney: A Unified Hypothesis to Explain the Renoprotective Effects of Sodium-Glucose Cotransporter 2 InhibitorsPacker, M. (Dallas, TX/London)


266 Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Acute Kidney Disease after an Episode of AKI: A Multicenter Prospective Cohort StudyHines, A. (Lexington, KY); Li, X. (Dallas, TX); Ortiz-Soriano, V.; Saleh, S.; Litteral, J.; Ruiz-Conejo, M. (Lexington, KY); Wald, R. (Toronto, ON); Silver, S.A. (Kingston, ON); Neyra, J.A. (Lexington, KY)

No. 5


349 Competing Effects of Renin Angiotensin System Blockade and Sodium-Glucose Cotransporter-2 Inhibitors on Erythropoietin Secretion in DiabetesMarathias, K.P.; Lambadiari, V.A.; Markakis, K.P.; Vlahakos, V.D.; Bacharaki, D.; Raptis, A.E.; Dimitriadis, G.D.; Vlahakos, D.V. (Athens)

Transplantation: Research Articles

357 IgA Nephropathy Recurrence after Kidney Transplantation: Role of Recipient Age and Human Leukocyte Antigen-B MismatchRodas, L.M.; Ruiz-Ortiz, E.; Garcia-Herrera, A.; Pereira, A.; Blasco, M.; Ventura-Aguiar, P.; Viñas Gomis, O.; Egri, N.; De Sousa, E.; Palou, E.; Diekmann, F.; Poch, E.; Campistol, J.M.; Quintana, L.F. (Barcelona)

366 Effect of Interleukin-2 Receptor Antibody Induction Therapy on Survival in Renal Transplant Patients Receiving TacrolimusAli, H.; Sharma, A. (Liverpool); Halawa, A. (Liverpool/Sheffield)

373 Endostatin Is an Independent Risk Factor of Graft Loss after Kidney TransplantChu, C. (Berlin/Heidelberg); Hasan, A.A. (Potsdam/Zagazig); Gaballa, M.M.S. (Heidelberg/Toukh); Zeng, S. (Berlin/Heidelberg); Xiong, Y.; Elitok, S. (Heidelberg/Potsdam); Krämer, B.K. (Heidelberg); Hocher, B. (Heidelberg/Changsha/Berlin)


381 Adverse Effects of Autoclaved Diets on the Progression of Chronic Kidney Disease and Chronic Kidney Disease-Mineral Bone Disorder in RatsBiruete, A.; Srinivasan, S.; O’Neill, K.D. (Indianapolis, IN); Vorland, C.J. (Bloomington, IN/West Lafayette, IN); Hill Gallant, K.M. (Indianapolis, IN/ West Lafayette, IN); Cai, W.; Uribarri, J. (New York, NY); Johnston, N.; Allen, M.R.; Chen, N.X.; Moe, S.M. (Indianapolis, IN)


343 Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, ChinaWang, L.; Li, X.; Chen, H.; Yan, S.; Li, D.; Li, Y.; Gong, Z. (Wuhan)

390 Relapse of Nephrotic Syndrome after Adrenocorticotropic Hormone-Induced Remission: Implications of Adrenocorticotropic Hormone AntibodiesShrivastava, S.; Chen, B.; Dworkin, L.D.; Malhotra, D.K.; Gong, R. (Toledo, OH)

395 A Simple Equation to Estimate Urinary Flow Rate Using Urine CreatinineWebster, L. (San Diego, CA); Larive, B.; Gassman, J. (Cleveland, OH); Bullen, A. (San Diego, CA); Weisbord, S.D.; Palevsky, P.M.; Fried, L.F. (Pittsburgh, PA); Raphael, K. (Salt Lake City, UT); Isakova, T. (Chicago, IL); Ix, J.H. (San Diego, CA/La Jolla, CA)


401 Recombinant Cellular Repressor of E1A-Stimulated Genes Protects against Renal Fibrosis in Dahl Salt-Sensitive RatsLiu, M.-L.; Song, H.-X.; Tian, X.-X.; Liu, Y.-X.; Liu, D.; Hou, Z.-W.; Li, J.-Y.; Yan, C.-H.; Han, Y. (Shenyang)

411 Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Diabetic and Non-Diabetic Chronic Kidney DiseaseSchoina, M.; Loutradis, C.; Minopoulou, I.; Theodorakopoulou, M.; Pyrgidis, N.; Tzanis, G.; Pella, E.; Papadopoulos, R.; Papagianni, A.; Sarafidis, P.A. (Thessaloniki)

Special Report

337 A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary DiseaseFerrey, A.J.; Choi, G.; Hanna, R.M.; Chang, Y.; Tantisattamo, E.; Ivaturi, K.; Park, E.; Nguyen, L.; Wang, B.; Tonthat, S. (Orange, CA); Rhee, C.M. (Orange, CA/ Long Beach, CA); Reddy, U. (Orange, CA); Lau, W.L. (Orange, CA/Long Beach, CA); Huang, S.S.; Gohil, S.; Amin, A.N.; Hsieh, L.; Cheng, T.T.; Lee, R.A. (Orange, CA); Kalantar-Zadeh, K. (Orange, CA/ Long Beach, CA)

No. 6

Editorial

421 Analgesic Polypharmacy Is a Likely Link to Increased Hospital AdmissionsFudin, J. (Springfield, MA/Albany, NY/Delmar, NY); Persico, A. (Albany, NY)


433 Associations between Proton Pump Inhibitor and Histamine-2 Receptor Antagonist and Bone Mineral Density among Kidney Transplant RecipientsLyu, B.; Hansen, K.E.; Jorgenson, M.R.; Astor, B.C. (Madison, WI)


424 Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis PatientsWaddy, S.P. (Decatur, GA); Becerra, A.Z.; Ward, J.B. (Silver Spring, MD); Chan, K.E. (Bethesda, MD); Fwu, C.-W. (Silver Spring, MD); Eggers, P.W.; Abbott, K.C.; Kimmel, P.L. (Bethesda, MD)

442 Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid ResistanceTong, J.; Jin, Y.; Weng, Q.; Yu, S.; Jafar Hussain, H.M.; Ren, H.; Xu, J.; Zhang, W.; Li, X.; Wang, W.; Xie, J.; Chen, N. (Shanghai)

VIII ContentsAm J Nephrol Vol. 51, 2020

453 New Criterion to Evaluate Acute-on-Chronic Kidney Injury Based on the Creatinine Reference ChangeXu, X.; Wang, L.; Xiong, M.; Nie, S. (Guangzhou); Liu, Z. (Zhengzhou); Feng, Y. (Chengdu); Chen, C. (Guangzhou); Zha, Y. (Guiyang); Ou, J. (Guilin); Ge, S. (Wuhan); Chen, J. (Hangzhou); Wan , Q. (Shenzhen); Teng, S. (Dalian); Hao, C.-M. (Shanghai); Liu, B.-C. (Nanjing); Xu, A. (Guangzhou); Feng , J.-H. (Hangzhou); Zhang, A. (Nanjing); Mao, J. (Hangzhou); Liu, H.-P. (Hefei); Liang, H. (Guangzhou); Shen, Q. (Shanghai); Feng, S. (Chengdu); Zhou, W. (Shanghai); Liu, X. (Jinan); Yang, Y. (Lanzhou); Tao, Y. (Chengdu); Wang, M. (Chongqing); Wang, L.-J.; Qi, J.-L. (Beijing); Li, Y.; Su, L.; Hou, F.F. (Guangzhou)

463 Chronic Kidney Disease Awareness and Longitudinal Health Outcomes: Results from the REasons for Geographic And Racial Differences in Stroke StudyTummalapalli, S.L.; Vittinghoff, E. (San Francisco, CA); Crews, D.C. (Baltimore, MD); Cushman, M. (Burlington, VT); Gutiérrez, O.M.; Judd, S.E. (Birmingham, AL); Kramer, H.J. (Chicago, IL); Peralta, C.A.; Tuot, D.S.; Shlipak, M.G.; Estrella, M.M. (San Francisco, CA)

473 KIM-1 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease: HALT-PKD ResultsGriffin, B.R. (Iowa City, IA); You, Z. (Aurora, CO); Noureddine, L. (Iowa City, IA); Gitomer, B.; Perrenoud, L.; Wang, W.; Chonchol, M. (Aurora, CO); Jalal, D. (Iowa City, IA); the HALT Investigators

Perspective

480 Telenephrology with Remote Peritoneal Dialysis Monitoring during Coronavirus Disease 19El Shamy, O. (New York, NY); Tran, H. (Deerfiled, IL); Sharma, S. (New York, NY); Ronco, C. (Vicenza); Narayanan, M. (Temple, TX); Uribarri, J. (New York, NY)


483 A Validation of the 2018 Revision of International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: A Cohort Study from ChinaTao, J.; Wang, H.; Yu, X.-J.; Tan, Y.; Yu, F.; Wang, S.-X. (Beijing); Haas, M. (Los Angeles, CA); Glassock, R.J. (Laguna Niguel, CA); Zhao, M.-H. (Beijing)

493 Protocol and Baseline Data of a Multicentre Prospective Double-Blinded Randomized Study of Intravenous Iron on Functional Status in Patients with Chronic Kidney DiseaseBhandari, S. (Hull/York); Allgar, V. (York); Lamplugh, A. (Hull); Macdougall, I.C. (London); Kalra, P.A. (Salford)

No. 7


501 Frailty Prevalence in Younger End-Stage Kidney Disease Patients Undergoing Dialysis and TransplantationChu, N.M.; Chen, X. (Baltimore, MD); Norman, S.P. (Ann Arbor, MI); Fitzpatrick, J. (Toronto, ON); Sozio, S.M.; Jaar, B.G.; Frey, A. (Baltimore, MD); Estrella, M.M. (San Francisco, CA); Xue, Q.-L. (Baltimore, MD); Parekh, R.S. (Toronto, ON); Segev, D.L.; McAdams-DeMarco, M.A. (Baltimore, MD)

511 Prophylactic Ligature of AV Fistula Prevents High Output Heart Failure after Kidney TransplantationHetz, P.; Pirklbauer, M.; Müller, S.; Posch, L.; Gummerer, M.; Tiefenthaler, M. (Innsbruck)


520 SOCS2 Silencing Improves Somatic Growth without Worsening Kidney Function in CKDLandau, D. (Petach Tikva/Tel Aviv); Assadi, M.H.; Abu Hilal, R. (Beer Sheva); Chen, Y.; Rabkin, R. (Stanford, CA/Palo Alto, CA); Segev, Y. (Beer Sheva)

527 Impact of Kidney Disease on Peripheral Arterial Interventions: A Systematic Review and Meta-AnalysisAnantha-Narayanan, M.; Sheikh, A.B.; Nagpal, S.; Smolderen, K.G.; Turner, J.; Schneider, M.; Llanos-Chea, F.; Mena-Hurtado, C. (New Haven, CT)

534 Neonatal and Maternal Outcomes among Women with GlomerulonephritisMadej, A.; Mazanowska, N.; Cyganek, A.; Pazik, J.; Pietrzak, B. (Warsaw)

542 Design and Baseline Characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) TrialAgarwal, R.; Cramer, A.E.; Balmes-Fenwick, M.; Sinha, A.D.; Ouyang, F.; Tu, W. (Indianapolis, IN)

Perspective

553 SGLT-2 Inhibitors to Treat Hyponatremia Associated with SIADH: A Novel Indication?Sarafidis, P. (Thessaloniki); Loutradis, C. (Thessaloniki/Birmingham); Ferro, C.J. (Birmingham); Ortiz, A. (Madrid)


556 Semaphorin-3C Is Upregulated in Polycystic Kidney Epithelial Cells and Inhibits Angiogenesis of Glomerular Endothelial CellsKim, B.H.; Kim, D.Y.; Ahn, Y.; Lee, E.J.; Park, H.; Park, M.; Park, J.H. (Seoul)

565 Branched-Chain Amino Acids Depletion during Hemodialysis Is Associated with FatigueDebnath, S.; Lorenzo, C.; Bansal, S.; Morales, J.; Rueda, R.O.; Kasinath, B.S.; Sharma, K.; O’Connor, J.C. (San Antonio, TX)

Letters to the Editor

572 The Fuzzy Connection between SARS-CoV-2 Infection and Loss of Renal FunctionBhaskar, L.V.K.S. (Bilaspur); Roshan, B. (La Jolla, CA); Nasri, H. (Isfahan)

574 Misleading Numbers: Is the Risk of Acute Kidney Injury with COVID-19 Truly This Low?Silver, S.A. (Kingston, ON); Clark, E.G.; Hiremath, S. (Ottawa, ON)

576 SARS-CoV-2 Infection Results in Serious Kidney Impairment: More Studies Need to Be ExploredWang, L.; Gong, Z. (Wuhan)

579 Nomenclature for Kidney Function and Disease: Executive Summary and Glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus ConferenceLevey, A.S. (Boston, MA); Eckardt, K.-U. (Berlin); Dorman, N.M. (Philadelphia, PA); Christiansen, S.L. (Chicago, IL); Cheung, M.; Jadoul, M. (Brussels); Winkelmayer, W.C. (Houston, TX)

IXContents Am J Nephrol Vol. 51, 2020

No. 8

Editorial

613 I Would Not Be Surprised. What Next?Perry, L.P.; Covinsky, K.E. (San Francisco, CA)


589 Assessment of Hydration Status in Peritoneal Dialysis Patients: Validity, Prognostic Value, Strengths, and Limitations of Available TechniquesAlexandrou, M.-E. (Thessaloniki); Balafa, O. (Ioannina); Sarafidis, P. (Thessaloniki)


615 Obesity: An Independent Predictor of Morbidity and Graft Loss after Kidney TransplantationAziz, F.; Ramadorai, A.; Parajuli, S.; Garg, N.; Mohamed, M.; Mandelbrot, D.A.; Foley, D.P.; Garren, M.; Djamali, A. (Madison, WI)


624 The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 CasesZhu, B. (Hangzhou); Liu, W. (Xining); Yu, D.; Lin, Y. (Hangzhou); Li, Q. (Sydney, NSW); Tong, M.; Li, Y.; Yang, R.; Du, Y.; Tang, X.; Jiang, F.; Fei, D.; Wei, X.; Zhang, F.; Yin, J.; Wang, W.; Li, X.; Sun, Y.; Zhong, Y.; Zhang, M.; Cheng, X.-X.; Zhu, C.; Chen, H. (Hangzhou)

635 Assessment of the CHA2DS2-VASc Score in Predicting Mortality and Adverse Cardiovascular Outcomes of Patients on HemodialysisSchamroth Pravda, M.; Cohen Hagai, K.; Topaz, G. (Kfar Saba); Schamroth Pravda, N. (Petach Tikvah); Makhoul, N. (Tel-Aviv); Shuvy, M. (Jerusalem); Benchetrit, S.; Assali, A.; Pereg, D. (Kfar Saba/Tel-Aviv); Pereg, D. (Kfar Saba/Tel-Aviv)

641 Nephrology Provider Surprise Question Response and Hospitalizations in Older Adults with Advanced CKDRamer, S.J. (New York, NY); Baddour, N.A. (Seattle, WA); Siew, E.D. (Nashville, TN); Salat, H. (Bronx, NY); Bian, A.; Stewart, T.G. (Nashville, TN); Wong, S.P.Y. (Seattle, WA); Jhamb, M. (Pittsburgh, PA); Abdel-Kader, K. (Nashville, TN)

650 Changes in Quality of Life in Older Hemodialysis Patients: A Cohort Study on Dialysis Outcomes and Practice PatternsIshiwatari, A. (Tokyo); Yamamoto, S.; Fukuma, S. (Kyoto); Hasegawa, T. (Tokyo/Fukushima); Wakai, S.; Nangaku, M. (Tokyo)

659 Increased Incident Ischemic Stroke Risk in Advanced Kidney Disease: A Large-Scale Real-World Data StudyMaeda, T.; Nishi, T.; Funakoshi, S.; Tada, K.; Tsuji, M.; Satoh, A.; Kawazoe, M.; Yoshimura, C.; Arima, H. (Fukuoka)


669 COVID-19 in Hospitalized Patients on Chronic Peritoneal Dialysis: A Case SeriesSachdeva, M.; Uppal, N.N. (Great Neck, NY); Hirsch, J.S. (Great Neck, NY/ Manhasset, NY/New Hyde Park, NY); Ng, J.H.; Malieckal, D.; Fishbane, S.; Jhaveri, K.D. (Great Neck, NY); the Northwell COVID-19 Research Consortium and the Northwell Nephrology COVID-19 Research Consortium

No. 9

675 Publisher’s Note

Editorial

693 APOL1, Acidity, and ATP: Affecting Mitochondrial FunctionKopp, J.B. (Bethesda, MD)


695 An Acidic Environment Induces APOL1-Associated Mitochondrial FragmentationLi, D.F. (Greensboro, NC/Winston-Salem, NC); Snipes, J.A.; Murea, M.; Molina, A.J.A.; Divers, J.; Freedman, B.I.; Ma, L.; Petrovic, S. (Winston-Salem, NC)

705 Mobility Impairment in Patients New to DialysisMoorthi, R.N.; Fadel, W.F.; Cranor, A.; Hindi, J.; Avin, K.G.; Lane, K.A. (Indianapolis, IN); Thadhani, R.I. (Boston, MA); Moe, S.M. (Indianapolis, IN)

715 Mortality Risk in Chronic Kidney Disease Patients Transitioning to Dialysis: Impact of Opiate and Non-Opiate UseYou, A.S. (Orange, CA); Kalantar-Zadeh, K.; Streja, E. (Orange, CA/Long Beach, CA); Park, C. (Orange, CA/ Seattle, WA); Sim, J.J. (Los Angeles, CA); Tantisattamo, E. (Orange, CA); Hsiung, J.-T. (Orange, CA/Long Beach, CA); Obi, Y.; Potukuchi, P.K. (Memphis, TN); Amin, A.N.; Nguyen, D.V. (Orange, CA); Kovesdy, C.P. (Memphis, TN); Rhee, C.M. (Orange, CA)

726 Cardiovascular Determinants of Mortality in Advanced Chronic Kidney DiseaseLankinen, R.; Hakamäki, M.; Metsärinne, K.; Koivuviita, N.S.; Pärkkä, J.P.; Hellman, T.; Kartiosuo, N.; Raitakari, O.T.; Järvisalo, M.J. (Turku)

736 Use of a Supportive Kidney Care Video Decision Aid in Older Patients: A Randomized Controlled TrialEneanya, N.D. (Philadelphia, PA); Percy, S.G. (Boston, MA); Stallings, T.L.; Wang, W. (Philadelphia, PA); Steele, D.J.R. (Boston, MA); Germain, M.J. (Springfield, MA); Schell, J.O. (Pittsburgh, PA); Paasche-Orlow, M.K.; Volandes, A.E. (Boston, MA)

745 Genetics May Predict Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney DiseaseSekine, A.; Hoshino, J.; Fujimaru, T.; Suwabe, T.; Mizuno, H.; Kawada, M.; Hiramatsu, R.; Hasegawa, E.; Yamanouchi, M.; Hayami, N.; Mandai, S.; Chiga, M.; Kikuchi, H.; Ando, F.; Mori, T.; Sohara, E.; Uchida, S.; Sawa, N.; Takaichi, K.; Ubara, Y. (Tokyo)


676 AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3Liebisch, M.; Wolf, G. (Jena)

X ContentsAm J Nephrol Vol. 51, 2020


752 Podocyte Involvement in Renal Thrombotic Microangiopathy: A Clinicopathological StudyHu, Y.-F.; Tan, Y.; Yu, X.-J.; Wang, H.; Wang, S.-X.; Yu, F.; Zhao, M.-H. (Beijing)

No. 10

Editorial

761 Acute Kidney Injury in COVID-19: Another Challenge for NephrologyRudnick, M.R.; Hilburg, R. (Philadelphia, PA)


764 Genotype-Guided Hydralazine TherapyCollins, K.S.; Raviele, A.L.J. (Indianapolis, IN); Elchynski, A.L. (Gainesville, FL); Woodcock, A.M. (Indianapolis, IN); Zhao, Y.; Cooper-DeHoff, R.M. (Gainesville, FL); Eadon, M.T. (Indianapolis, IN)


777 Characteristics and Graft Survival of Kidney Transplant Recipients with Renal Cell CarcinomaMachhi, R.; Mandelbrot, D.A.; Al-Qaoud, T.; Astor, B.C.; Parajuli, S. (Madison, WI)


786 Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy ImplicationsZahid, U.; Ramachandran, P.; Spitalewitz, S.; Alasadi, L.; Chakraborti, A.; Azhar, M.; Mikhalina, G.; Sherazi, A.; Narh, JT. (Brooklyn, NY); Khattar, P. (New York, NY); Bedi, P. (Brooklyn, NY)

Patient-Oriented, Translational Research: Research Article

797 Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT ParticipantsJotwani, V. (San Francisco, CA); Garimella, P.S. (San Diego, CA); Katz, R. (Seattle, WA); Malhotra, R. (San Diego, CA); Bates, J. (Houston, TX); Cheung, A.K. (Salt Lake City, UT); Chonchol, M. (Aurora, CO); Drawz, P.E. (Minneapolis, MN); Freedman, B.I. (Winston-Salem, NC); Haley, W.E. (Jacksonville, FL); Killeen, A.A. (Minneapolis, MN); Punzi, H. (Carollton, TX); Sarnak, M.J. (Boston, MA); Segal, M.S. (Gainesville, FL); Shlipak, M.G. (San Francisco, CA); Ix, J.H. (San Diego, CA)

806 Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney DiseaseWang, X.; Zhang, H.; Zhang, Q.; Guan, M.; Sheng, S.; Mo, W.; Zou, M.; Li, J.; Bi, J.; Tang, X.; Zeng, H.; He, J.; Xu, G.; Li, P.; Xue, Y. (Guangzhou)

815 Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis PatientsDanese, M.D.; Lubeck, D. (Agoura Hills, CA); Belozeroff, V.; Lin, T.-C.; Desai, P. (Thousand Oaks, CA); Gleeson, M. (Agoura Hills, CA); Martin, K. (St. Louis, MO); Chonchol, M. (Aurora, CO)


823 Relationship between Serum Uric Acid and Mortality Risk in Hemodialysis Patients: A Multicenter Prospective Cohort StudyYang, Y.; Qin, X.; Li, Y.; Yang, S.; Chen, J.; He, Y.; Huang, Y.; Lin, Z.; Li, Y. (Guangzhou); Kong, Y. (Foshan); Lu, Y.; Zhao, Y. (Yuxi); Wan, Q. (Shenzhen); Wang, Q. (Guangzhou); Huang, S. (Foshan); Liu, Y.; Liu, A.; Liu, F.; Hou, F.F.; Liang, M. (Guangzhou)

833 Cortical Bone Microarchitecture in Dialysis PatientsBenillouche, E.; Ostertag, A.; Marty, C. (Paris); Ureña Torres, P. (Saint-Ouen); Cohen-Solal, M. (Paris)

839 A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 DiabetesLimonte, C.P. (Seattle, WA); Valo, E. (Helsinki); Montemayor, D. (San Antonio, TX); Afshinnia, F. (Ann Arbor, MI); Ahluwalia, T.S. (Copenhagen); Costacou, T. (Pittsburgh, PA); Darshi, M. (San Antonio, TX); Forsblom, C. (Helsinki); Hoofnagle, A.N. (Seattle, WA); Groop, P.-H. (Helsinki); Miller, R.G.; Orchard, T.J. (Pittsburgh, PA); Pennathur, S. (Ann Arbor, MI); Rossing, P. (Copenhagen); Sandholm, N. (Helsinki); Snell-Bergeon, J.K. (Aurora, CO); Ye, H. (San Antonio, TX); Zhang, J.; Natarajan, L. (La Jolla, CA); de Boer, I.H. (Seattle, WA); Sharma, K. (San Antonio, TX)

No. 11

Commentary

849 NET Formation in Dialysis: A Valuable, albeit Mysterious and Enticing Predictor of MortalityGoligorsky, M.S. (Valhalla, NY)


852 Elevated Circulating Cell-Free DNA in Hemodialysis-Treated Patients Is Associated with Increased MortalityEinbinder, Y. (Kfar Saba/Tel Aviv); Shnaider, A. (Beer-Sheva); Ghanayem, K. (Tel Aviv); Basok, A.; Rogachev, B.; Lior, Y.; Haviv, Y.S. (Beer-Sheva); Cohen-Hagai, K. (Kfar Saba/Tel Aviv); Nacasch, N.; Rozenberg, I. (Kfar Saba); Benchetrit, S.; Zitman-Gal, T. (Kfar Saba/Tel Aviv); Douvdevani, A. (Beer-Sheva)

XIContents Am J Nephrol Vol. 51, 2020

861 Effect of Vasopressin on the Hypothalamic-Pituitary-Adrenal Axis in ADPKD Patients during V2 Receptor AntagonismHeida, J.E.; Minović, I.; van Faassen, M.; Kema, I.P.; Boertien, W.E.; Bakker, S.J.L.; van Beek, A.P.; Gansevoort, R.T. (Groningen)

871 Circulating Levels of Dickkopf-Related Protein 1 Decrease as Measured GFR Declines and Are Associated with PTH LevelsForster, C.M.; White, C.A.; Turner, M.E.; Norman, P.A.; Ward, E.C.; Hopman, W.M.; Adams, M.A.; Holden, R.M. (Kingston, ON)

881 Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for TolvaptanHigashihara, E.; Horie, S.; Muto, S.; Kawano, H.; Tambo, M.; Yamaguchi, T.; Taguchi, S.; Kaname, S.; Yokoyama, K.; Yoshioka, T.; Furukawa, T.; Fukuhara, H. (Tokyo)


891 Recovery of Renal Function following Kidney-Specific VEGF Therapy in Experimental Renovascular DiseaseEngel, J.E.; Williams, M.L.; Williams, E.; Azar, C.; Taylor, E.B.; Bidwell, G.L.; Chade, A.R. (Jackson, MS)

Perspective

903 The Effect of Kidney Biopsy on Glomerular Filtration Rate: A Frequent Patient ConcernDattani, R.; Corbett, R.W.; Galliford, J.; Hill, P.; Cairns, T.; Cook, H.T.; Roufosse, C.; Ashby, D.R. (London)


907 Serum Lysyl Oxidase Is a Potential Diagnostic Biomarker for Kidney FibrosisZhang, X.; Li, X.; Zhou, W.; Liu, X.; Huang, J.; Zhang, Y. (Shanghai); Lindholm, B. (Stockholm); Yu, C. (Shanghai)

919 Leisure-Time Physical Activity and Mortality in CKD: A 1999–2012 NHANES AnalysisZhang, N.-H.; Luo, R.; Cheng, Y.-C.; Ge, S.-W.; Xu, G. (Wuhan)

930 Erratum

No. 12


931 Assessment of Endothelial and Microvascular Function in CKD: Older and Newer Techniques, Associated Risk Factors, and Relations with OutcomesTheodorakopoulou, M.P.; Schoina, M.; Sarafidis, P.A. (Thessaloniki)


950 Cellular Senescence Is Associated with Faster Progression of Focal Segmental GlomerulosclerosisVerzola, D.; Saio, M.; Picciotto, D.; Viazzi, F.; Russo, E.; Cipriani, L.; Carta, A.; Costigliolo, F.; Gaggero, G.; Salvidio, G.; Esposito, P.; Garibotto, G.; Poggi, L. (Genova)

959 Availability and Affordability of Kidney Health Laboratory Tests around the GlobeTummalapalli, S.L. (San Francisco, CA/New York, NY); Shlipak, M.G. (San Francisco, CA); Damster, S. (Brussels); Jha, V. (New Delhi/London/Manipal); Malik, C. (Brussels); Levin, A. (Vancouver, BC); Johnson, D.W. (Brisbane, QLD); Bello, A.K. (Edmonton, AB)

966 Medullary Blood Oxygen Level-Dependent MRI Index (R2*) is Associated with Annual Loss of Kidney Function in Moderate CKDLi, L.-P. (Evanston, IL/Chicago, IL); Thacker, J.M. (Evanston, IL); Li, W. (Evanston, IL/Chicago, IL); Hack, B.; Wang, C. (Evanston, IL); Kohn, O. (Chicago, IL); Sprague, S.M. (Chicago, IL/Evanston, IL); Prasad, P.V. (Evanston, IL/ Chicago, IL)

975 Health Insurance Status Is Related to Risk of Mortality and Hospitalization in Korean Maintenance Hemodialysis Patients: A Longitudinal Cohort StudyPark, H.C. (Seoul); Kwon, Y.-E. (Goyang); Choi, H.Y.; Oh, H.J. (Seoul); Chang, T.I.; Kang, E.W.; Park, K.S. (Goyang); Yang, K.H.; Won, E.M.; Shin, J.H. (Wonju); Ryu, D.-R.; Lee, Y.-K. (Seoul)

982 Percutaneous Renal Biopsy Using an 18-Gauge Automated Needle Is Not OptimalSousanieh, G.; Whittier, W.L.; Rodby, R.A.; Peev, V.; Korbet, S.M. (Chicago, IL)

988 Hemodilution Impacts Assessment of Thyroid Status before and after Hemodialysis in Patients with End-Stage Renal DiseaseSanai, T. (Fukuoka/Saga); Okamura, K.; Onoue, T.; Ono, T. (Fukuoka); Motomura, K. (Fukuoka/Onojo); Miyazono, M. (Saga); Shimamatsu, K. (Fukuoka/Chikushino)

995 Mortality and Hospitalizations among Sickle Cell Disease Patients with End-Stage Kidney Disease Initiating DialysisOlaniran, K.O. (Dallas, TX); Eneanya, N.D. (Philadelphia, PA); Zhao, S.H. (Boston, MA); Ofsthun, N.J. (Waltham, MA); Maddux, F.W. (Waltham, MA/Bad Homburg); Thadhani, R.I. (Boston, MA); Dalrymple, L.S. (Waltham, MA); Nigwekar, S.U. (Boston, MA)

1004 Acknowledgement to the Reviewers

AJN American Journal of Nephrology - Karger Publishers

Documents